@article{d739b11a9a60435589118c08459d968c,
title = "Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial",
author = "{CATALYST investigators} and Fisher, {Benjamin A.} and Tonny Veenith and Daniel Slade and Charlotte Gaskell and Matthew Rowland and Tony Whitehouse and James Scriven and Dhruv Parekh and Balasubramaniam, {Madhu S.} and Graham Cooke and Nick Morley and Zoe Gabriel and Wise, {Matthew P.} and Joanna Porter and Helen McShane and Ho, {Ling Pei} and Newsome, {Philip N.} and Anna Rowe and Rowena Sharpe and Thickett, {David R.} and Julian Bion and Simon Gates and Duncan Richards and Pamela Kearns and Bryan Williams and Rebecca Turner and Vincenzo Libri and Francis Mussai and Gary Middleton and Sarah Bowden and Mansoor Bangash and Fang Gao-Smith and Jaimin Patel and Elizabeth Sapey and Mark Thomas and Mark Coles and Peter Watkinson and Naj Rahman and Brian Angus and Mentzer, {Alexander J.} and Alex Novak and Marc Feldman and Alex Richter and Sian Faustini and Camilla Bathurst and {Van de Wiel}, Joseph and Susie Mee and Karen James and Bushra Rahman and Karen Turner",
note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",
year = "2022",
month = mar,
doi = "10.1016/S2213-2600(21)00460-4",
language = "English",
volume = "10",
pages = "255--266",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Limited",
number = "3",
}